In the world of pharmaceutical manufacturing, biotechnology, and advanced material production, cleanrooms serve as the backbone of contamination control. However, designing and maintaining a compliant cleanroom is not just about meeting regulatory expectations—it is about ensuring safe, consistent, and high-quality manufacturing processes.
Nelson Labs, a global leader in microbiological and analytical chemistry testing, has unveiled its cutting-edge Rapid Sterility Testing service, an innovation poised to significantly expedite product release timelines for pharmaceutical and medical device manufacturers.
Clarios, the Wisconsin-based global leader in low-voltage energy storage, announced a $6 billion plan expected to expand U.S. manufacturing and accelerate American innovation. The plan aims to advance American energy and critical mineral independence by strengthening the nation’s critical supply of batteries essential to start every vehicle in the U.S. The plan would expand existing operations, build new facilities, unlock innovation and create American jobs enabled by recent executive orders and using federal advanced manufacturing tax credits.
Eli Lilly and Company announced plans to bolster its domestic medicine production across therapeutic areas by building four new pharmaceutical manufacturing sites in the United States.
The implementation of EU GMP Annex 1 marks a transformative shift for the sterile filling industry. With new requirements emphasizing barrier technology and “first air” contamination control, pharmaceutical manufacturers face critical decisions in adapting their processes. Johannes Rauschnabel of Syntegon explores how equipment suppliers can play a pivotal role in facilitating compliance and seamless integration of these advanced standards.
